Zobrazeno 1 - 10
of 93
pro vyhledávání: '"Carla A Winston"'
Publikováno v:
PLoS ONE, Vol 11, Iss 2, p e0147353 (2016)
While the number of reported tuberculosis (TB) cases in the United States has declined over the past two decades, TB morbidity among foreign-born persons has remained persistently elevated. A recent unexpected decline in reported TB cases among forei
Externí odkaz:
https://doaj.org/article/079a67dd0fd44133b686aa53ccefc2c3
Autor:
Julie A Pavlin, Howard S Burkom, Yevgeniy Elbert, Cynthia Lucero-Obusan, Carla A Winston, Kenneth L Cox, Gina Oda, Joseph S Lombardo, Mark Holodniy
Publikováno v:
PLoS ONE, Vol 8, Iss 12, p e84077 (2013)
BACKGROUND: The U.S. Department of Veterans Affairs (VA) and Department of Defense (DoD) had more than 18 million healthcare beneficiaries in 2011. Both Departments conduct individual surveillance for disease events and health threats. METHODS: We pe
Externí odkaz:
https://doaj.org/article/9c88b3ed38e64a6b929f49ca03e34d74
Publikováno v:
PLoS ONE, Vol 8, Iss 6, p e65276 (2013)
In 2010, foreign-born persons accounted for 60% of all tuberculosis (TB) cases in the United States. Understanding which national groups make up the highest proportion of TB cases will assist TB control programs in concentrating limited resources whe
Externí odkaz:
https://doaj.org/article/84290777de2b43469560e6debee95f00
Publikováno v:
PLoS ONE, Vol 7, Iss 10, p e47855 (2012)
BACKGROUND: In patients with HIV and tuberculosis (TB) in resource-constrained settings, smear-negative disease has been associated with higher mortality than smear-positive disease. Higher reported mortality may be due to misdiagnosis, diagnostic de
Externí odkaz:
https://doaj.org/article/b9d781958dee4ea3b8fcda0c0f28f3ec
Publikováno v:
Emerging Infectious Diseases, Vol 29, Iss 10, Pp 2102-2104 (2023)
We estimated direct costs of a 4-month or 6-month regimen for drug-susceptible pulmonary tuberculosis treatment in the United States. Costs were $23,000 per person treated. Actual treatment costs will vary depending on examination and medication char
Externí odkaz:
https://doaj.org/article/56c67aa783e74d01ae1af0a673524685
Autor:
Joan M. Mangan, Rachel S. Woodruff, Carla A. Winston, Scott A. Nabity, Maryam B. Haddad, Meredith G. Dixon, Farah M. Parvez, Carissa Sera-Josef, LaTweika A. T. Salmon-Trejo, Chee Kin Lam
Publikováno v:
MMWR. Morbidity and Mortality Weekly Report. 72:313-316
Publikováno v:
Annals of the American Thoracic Society. 18:1669-1676
Rationale: A central strategy of tuberculosis (TB) control in the United States is reducing the burden of latent TB infection (LTBI) through targeted testing and treatment of persons with untreated LTBI. Objectives: The objective of the study was to
Publikováno v:
Tuberculosis Research and Treatment, Vol 2017 (2017)
Objective. To evaluate TB test usage and associated direct medical expenditures from 2013 private insurance claims data in the United States (US). Methods. We extracted outpatient claims for TB-specific and nonspecific tests from the 2013 MarketScan
Externí odkaz:
https://doaj.org/article/c7b2801155d74703a44660d02a619b5b
Autor:
Kenneth G. Castro, Thomas R. Navin, Andrew N. Hill, Timothy L. Lash, Neel R. Gandhi, Carla A. Winston, Maryam B. Haddad
Publikováno v:
Epidemiology
BACKGROUND: A single 2-year National Health and Nutrition Examination Survey (NHANES) cycle is designed to provide accurate and stable estimates of conditions with prevalence of at least 10%. Recent NHANES-based estimates of a tuberculin skin test
Autor:
Robert Belknap, Marcos Burgos, Philip A. LoBue, C. Robert Horsburgh, Charles M. Crane, Randall Reves, Dick Menzies, Gibril J. Njie, Carla A. Winston, David L. Cohn, Dominik Zenner, Amina Ahmed, Timothy R. Sterling
Publikováno v:
MMWR Recommendations and Reports
Summary Comprehensive guidelines for treatment of latent tuberculosis infection (LTBI) among persons living in the United States were last published in 2000 (American Thoracic Society. CDC targeted tuberculin testing and treatment of latent tuberculo